Germany - English - HMA (Heads of Medicines Agencies)

bayer b.v. – animal health division - phenoxymethylpenicillin sodium salt 325 mg/g - powder for oral solution - chicken - phenoxymethylpenicillin

Ireland - English - HPRA (Health Products Regulatory Authority)

morningside healthcare limited - phenoxymethylpenicillin - film coated tablet - 250 milligram - phenoxymethylpenicillin

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - phenoxymethylpenicillin benzathine -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - phenoxymethylpenicillin potassium - oral tablet - 250mg

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - phenoxymethylpenicillin, quantity: 500 mg - capsule, hard - excipient ingredients: erythrosine; titanium dioxide; sunset yellow fcf; brilliant blue fcf; magnesium stearate; gelatin; indigo carmine; allura red ac; quinoline yellow aluminium lake; iron oxide black; sd alcohol 3-a - penicilin v potassium is indicated in the treatment of mild to moderately severe infections due to penicillin v sensitive micro-organisms. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. note: severe pneumonia, empyema, bacteraemia, pericarditis, meningitis and arthritis should not be treated with penicillin v during the acute stage. indicated surgical procedures should be performed.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - powder for suspension - clavulanic acid as potassium salt 11.4 mg/ml; amoxicillin as trihydrate 80 mg/ml - amoxicillin and enzyme inhibitor - augmentin is indicated for the treatment of the following infections in adults and children: • acute bacterial sinusitis (adequately diagnosed)• acute otitis media• acute exacerbations of chronic bronchitis (adequately diagnosed)• community acquired pneumonia• cystitis• pyelonephritis• skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• bone and joint infections, in particular osteomyelitis.• recurrent tonsillitis

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - powder for suspension - amoxicillin as trihydrate 600 mg / 5 ml; clavulanic acid as potassium salt 42.9 mg / 5 ml - amoxicillin and enzyme inhibitor - augmentin es is indicated for the treatment of acute otitis media in children aged at least 3 months and less than 40 kg body weight, caused or thought likely to be caused by penicillin-resistant streptococcus pneumoniae:consideration should be given to official guidance on the appropriate use of antibacterial agents.

Malta - English - Medicines Authority

central procurement & supplies unit - phenoxymethylpenicillin potassium - powder for oral solution - phenoxymethylpenicillin potassium 125 milligram(s)/5 millilitre - antibacterials for systemic use